Clinical Research Directory
Browse clinical research sites, groups, and studies.
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
Sponsor: Fujian Medical University Union Hospital
Summary
To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia, and to reduce related adverse reactions and economic burdens on the premise of ensuring the remission rate
Official title: A Multicenter, Randomized Controlled Study of Two Regimens of Intravenous Immune Globulin in the Treatment of Newly Diagnosed Immune Thrombocytopenia in Children
Key Details
Gender
All
Age Range
29 Days - 14 Years
Study Type
INTERVENTIONAL
Enrollment
580
Start Date
2022-10-06
Completion Date
2026-08-31
Last Updated
2024-05-16
Healthy Volunteers
No
Interventions
intravenous immunoglobulin
To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia
Locations (1)
Children with newly dignosed ITP
Fuzhou, Fujian, China